News
IP Law Podcast: Christopher Loh of Fitzpatrick Cella Harper & Scinto in New York City discusses the Amgen v. Sanofi CAFC decision and his paper “End of ‘well characterized antigen’ test?”
November 6, 2018
|
The International Intellectual Property Law Podcast Episode 49 Christopher Loh of Fitzpatrick Cella Harper & Scinto in New York City discusses the Amgen v. Sanofi CAFC decision and his paper “End of ‘well characterized antigen’ test?” Click here to listen.
|
